Roche Holding AG

RHO5

Company Profile

  • Business description

    Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.

  • Contact

    Grenzacherstrasse 124
    Basel4070
    CHE

    T: +41 616881111

    E: [email protected]

    https://www.roche.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2025

    Employees

    103,249

Roche Holding AG News & Analysis

stocks

Magnificent Seven vs. the ‘Granolas’: How does Europe’s version stack up?

‘Granolas’ stocks are profitable, diversified, cheap—and posting big returns.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,922.004.900.05%
CAC 407,617.6371.470.95%
DAX 4023,738.44312.471.33%
Dow JONES (US)43,588.58542.40-1.23%
FTSE 1009,112.9244.340.49%
HKSE24,733.45225.640.92%
NASDAQ20,650.13472.31-2.24%
Nikkei 22540,290.70508.90-1.25%
NZX 50 Index12,684.0445.36-0.36%
S&P 5006,238.01101.38-1.60%
S&P/ASX 2008,663.701.700.02%
SSE Composite Index3,583.3123.360.66%

Market Movers